Skip to Main Content

Author Details

Luigi Marchionni
Weill-Cornell School of Medicine
1989
132
43
PMIDPaper TitleJournal TitlePublished Year
37812042TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment.Prostate2024
37812042TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment.Prostate2024
36525970Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancer.Cancer Cell2023
37693379Tumor-Specific CD8<sup>+</sup> T Cells from the Bone Marrow Resist Exhaustion and Exhibit Increased Persistence in Tumor-Bearing Hosts as Compared to Tumor Infiltrating Lymphocytes.bioRxiv2023
37216914MultiNEP: a multi-omics network enhancement framework for prioritizing disease genes and metabolites simultaneously.Bioinformatics2023
36717286A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study.Eur Urol2023
37409050CALANGO: A phylogeny-aware comparative genomics tool for discovering quantitative genotype-phenotype associations across species.Patterns (N Y)2023
36759904REPAC: analysis of alternative polyadenylation from RNA-sequencing data.Genome Biol2023
36752203Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer.JCI Insight2023
36543879Recurrent germline variant in ATM associated with familial myeloproliferative neoplasms.Leukemia2023
36852282Using biological constraints to improve prediction in precision oncology.iScience2023
37419704Optimal fluid volume for detecting malignancy in serous effusions: a single institution experience.J Am Soc Cytopathol2023
37034687Distinct mesenchymal cell states mediate prostate cancer progression.bioRxiv2023
36525970Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancer.Cancer Cell2023
37693379Tumor-Specific CD8<sup>+</sup> T Cells from the Bone Marrow Resist Exhaustion and Exhibit Increased Persistence in Tumor-Bearing Hosts as Compared to Tumor Infiltrating Lymphocytes.bioRxiv2023
37419704Optimal fluid volume for detecting malignancy in serous effusions: a single institution experience.J Am Soc Cytopathol2023
37216914MultiNEP: a multi-omics network enhancement framework for prioritizing disease genes and metabolites simultaneously.Bioinformatics2023
37409050CALANGO: A phylogeny-aware comparative genomics tool for discovering quantitative genotype-phenotype associations across species.Patterns (N Y)2023
37034687Distinct mesenchymal cell states mediate prostate cancer progression.bioRxiv2023
36752203Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer.JCI Insight2023
36852282Using biological constraints to improve prediction in precision oncology.iScience2023
36717286A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study.Eur Urol2023
36543879Recurrent germline variant in ATM associated with familial myeloproliferative neoplasms.Leukemia2023
36759904REPAC: analysis of alternative polyadenylation from RNA-sequencing data.Genome Biol2023
34297428RNA-sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial neurofibromas.Brain Pathol2022
36038558ZNF92, an unexplored transcription factor with remarkably distinct breast cancer over-expression associated with prognosis and cell-of-origin.NPJ Breast Cancer2022
36282572A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas.J Clin Invest2022
35634961Precision health diagnostic and surveillance network uses S gene target failure (SGTF) combined with sequencing technologies to track emerging SARS-CoV-2 variants.Immun Inflamm Dis2022
36122486Rapid detection of SARS-CoV-2 variants of concern by single nucleotide polymorphism genotyping using TaqMan assays.Diagn Microbiol Infect Dis2022
35979657Donor-derived acute myeloid leukemia in solid organ transplantation.Am J Transplant2022
34297428RNA-sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial neurofibromas.Brain Pathol2022
34569064A robust and interpretable gene signature for predicting the lymph node status of primary T1/T2 oral cavity squamous cell carcinoma.Int J Cancer2022
34880124Building Tools for Machine Learning and Artificial Intelligence in Cancer Research: Best Practices and a Case Study with the PathML Toolkit for Computational Pathology.Mol Cancer Res2022
35634961Precision health diagnostic and surveillance network uses S gene target failure (SGTF) combined with sequencing technologies to track emerging SARS-CoV-2 variants.Immun Inflamm Dis2022
36038558ZNF92, an unexplored transcription factor with remarkably distinct breast cancer over-expression associated with prognosis and cell-of-origin.NPJ Breast Cancer2022
36122486Rapid detection of SARS-CoV-2 variants of concern by single nucleotide polymorphism genotyping using TaqMan assays.Diagn Microbiol Infect Dis2022
35979657Donor-derived acute myeloid leukemia in solid organ transplantation.Am J Transplant2022
36282572A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas.J Clin Invest2022
34880124Building Tools for Machine Learning and Artificial Intelligence in Cancer Research: Best Practices and a Case Study with the PathML Toolkit for Computational Pathology.Mol Cancer Res2022
34569064A robust and interpretable gene signature for predicting the lymph node status of primary T1/T2 oral cavity squamous cell carcinoma.Int J Cancer2022
32603552Global microRNA profiling identified miR-10b-5p as a regulator of neurofibromatosis 1 (NF1)-glioma migration.Neuropathol Appl Neurobiol2021
34115745Efficient representations of tumor diversity with paired DNA-RNA aberrations.PLoS Comput Biol2021
33568675Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes.Nat Commun2021
33991092covid19census: U.S. and Italy COVID-19 metrics and other epidemiological data.Database (Oxford)2021
33923159Influenza Vaccination and COVID-19 Mortality in the USA: An Ecological Study.Vaccines (Basel)2021
33819273An R package for divergence analysis of omics data.PLoS One2021
34311724Transcriptional landscape of PTEN loss in primary prostate cancer.BMC Cancer2021
33408119Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma.Cancer Res2021
32603552Global microRNA profiling identified miR-10b-5p as a regulator of neurofibromatosis 1 (NF1)-glioma migration.Neuropathol Appl Neurobiol2021
34746025Host Blood Gene Signatures Can Detect the Progression to Severe and Cerebral Malaria.Front Cell Infect Microbiol2021
  • 1 - 50 of 264

Recommended Authors

Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 7
Qiyuan Li
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 5
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 13
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 3
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 0
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 10
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 6
Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 7
Nathalie Pochet
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 1
Amy G Robertson
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 13
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 6
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2003
Number of shared co-authors 5
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 1
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 3
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 11
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 2
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 11
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 0
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 5
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 28
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 9
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 1
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 11
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 6
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 0
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 3
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 6
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 38

Collaborators

Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Co-authored papers 14
David M Berman
Queen's University
Co-authored papers 11
Giovanni Parmigiani
Dana Farber Cancer Institute.
Co-authored papers 11
Ashley E Ross
Northwestern University
Co-authored papers 10
Donald Geman
Johns Hopkins University
Co-authored papers 8
Claudio Schneider
Laboratorio Nazionale-Consorzio Interuniversitario per le Biotecnologie
Co-authored papers 7
Elana J Fertig
Johns Hopkins University School of Medicine
Co-authored papers 7
Brian W Simons
Center for Comparative Medicine, Baylor College of Medicine
Co-authored papers 7
Roberto Verardo
LNCIB - Consorzio Interuniversitario per le Biotecnologie c/o BIC Incubatori FVG
Co-authored papers 6
Piero Carninci
RIKEN Center for Integrative Medical Sciences
Co-authored papers 6
Fausto J Rodriguez
University of California Los Angeles
Co-authored papers 6
James F Reid
Co-authored papers 5
Masayoshi Itoh
RIKEN Center for Integrative Medical Sciences
Co-authored papers 5
Massimo Loda
Weill Medical College of Cornell University
Co-authored papers 5
Takeya Kasukawa
RIKEN Center for Integrative Medical Sciences
Co-authored papers 5
Hideya Kawaji
RIKEN Center for Integrative Medical Sciences
Co-authored papers 4
Wayne M Koch
Johns Hopkins University School of Medicine
Co-authored papers 4
Manuela Gariboldi
Co-authored papers 4
Tamara L Lotan
Johns Hopkins University School of Medicine
Co-authored papers 4
William H Westra
Icahn School of Medicine at Mount Sinai Hospital.
Co-authored papers 4
Elai Davicioni
Veracyte Inc.
Co-authored papers 4
Charles G Eberhart
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 4
Harukazu Suzuki
RIKEN Center for Integrative Medical Sciences
Co-authored papers 4
Emiliano Dalla
University of Udine
Co-authored papers 4
Graziano Pesole
Co-authored papers 4
William Matsui
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Co-authored papers 4
Kazuhiro Shibata
Co-authored papers 3
Colin F Fletcher
Co-authored papers 3
Stefano Gustincich
Istituto Italiano di Tecnologia
Co-authored papers 3
Martin S Taylor
Institute of Genetics and Cancer, University of Edinburgh
Co-authored papers 3
Release 1.2